These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 2816152
21. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH. Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655 [Abstract] [Full Text] [Related]
22. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)]. Amato NA, Partipilo V, Mele F, Boscia F, De Marzo P. Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656 [Abstract] [Full Text] [Related]
27. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Samuels JR, Yun HJ. Gynecol Oncol; 1998 Aug; 70(2):165-71. PubMed ID: 9740684 [Abstract] [Full Text] [Related]
28. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma. Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, Mychalczak BR, McKee B, Hoskins WJ, Barakat RR. Cancer; 2002 Jul 15; 95(2):316-21. PubMed ID: 12124832 [Abstract] [Full Text] [Related]
29. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Trattner M, Graf AH, Lax S, Forstner R, Dandachi N, Haas J, Pickel H, Reich O, Staudach A, Winter R. Gynecol Oncol; 2001 Jul 15; 82(1):11-6. PubMed ID: 11426955 [Abstract] [Full Text] [Related]
30. [Large volume stage I and II epidermoid carcinoma of the uterine cervix treated with primary radiotherapy and surgery]. Touboul E, Lefranc JP, Belkacémi Y, Rogel A, Deluen F, Blondon J, Housset M. Contracept Fertil Sex; 1998 Sep 15; 26(9):674-85. PubMed ID: 9823696 [Abstract] [Full Text] [Related]
31. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. Gynecol Oncol; 2000 Nov 15; 79(2):289-93. PubMed ID: 11063659 [Abstract] [Full Text] [Related]
32. Difference in prognostic factors between stage IB and II uterine cervical carcinoma patients treated with radical hysterectomy and postoperative radiation therapy. Niibe Y, Karasawa K, Kaizu T, Mizutani K, Ozaki Y, Nagano H, Ueda K, Murakami A, Tanaka Y. Radiat Med; 2002 Nov 15; 20(4):161-7. PubMed ID: 12296431 [Abstract] [Full Text] [Related]
36. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, DiSaia PJ, Berman ML. Gynecol Oncol; 1994 Jul 15; 54(1):4-9. PubMed ID: 8020837 [Abstract] [Full Text] [Related]
37. Risk for radical hysterectomy failure. Manusirivithaya S, Isariyodom P, Charoeniam V, Pantusart A. J Med Assoc Thai; 2001 Jun 15; 84(6):791-7. PubMed ID: 11556456 [Abstract] [Full Text] [Related]
38. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases]. Leung F, Terzibachian JJ, Aouar Z, Govyadovskiy A, Lassabe C. Gynecol Obstet Fertil; 2008 Jun 15; 36(6):628-35. PubMed ID: 18538624 [Abstract] [Full Text] [Related]
39. The significance of residual tumor after preoperative pelvic irradiation for stage II endometrial carcinoma. Larson DM, Copeland LJ, Gallager HS, Wharton JT, Gershenson DM, Rutledge FN. Obstet Gynecol; 1987 Dec 15; 70(6):916-9. PubMed ID: 3684130 [Abstract] [Full Text] [Related]
40. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Irie T, Kigawa J, Minagawa Y, Itamochi H, Sato S, Akeshima R, Terakawa N. Eur J Surg Oncol; 2000 Aug 15; 26(5):464-7. PubMed ID: 11016467 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]